# Resmed to acquire Noctrix Health for $340 million

Resmed entered a definitive merger agreement to acquire Noctrix Health for $340 million. Noctrix developed the Nidra Tonic Motor Activation System, a non-invasive wearable therapy for Restless Legs Syndrome. The acquisition is expected to close on or around June 1, 2026.

- Type: Acquisition
- Announced: 2026-05-05
- Where: United States
- Value: $340.0M
- Status: announced
- Products: Nidra Tonic Motor Activation System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ResMed](https://endata.com/companies/35402.md) (acquirer)
- [Noctrix Health](https://endata.com/companies/91744.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/resmed-enters-merger-agreement-to-acquire-noctrix-health-for-340-million/), 2026-05-05: "RLS treatments from Noctrix are non-invasive, clinically proven and drug-free, just like our CPAP, APAP and bi-level therapies."
- [barchart.com](https://www.barchart.com/press-releases/2242832/resmed-completes-acquisition-of-noctrix-health-expanding-clinical-sleep-health-portfolio), 2026-06-01: "Resmed today announced it has completed its acquisition of Noctrix Health, Inc., a medical device company developing clinically validated wearable therapeutics for chronic neurological disorders."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.